# Intestinal Lavage for the Treatment of Severe C. Difficile Infections

> **NCT02466698** · PHASE2,PHASE3 · UNKNOWN · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 20 (estimated)

## Conditions studied

- Clostridium Difficile

## Interventions

- **PROCEDURE:** Intestinal Lavage
- **DRUG:** Vancomycin
- **DRUG:** PEG
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT02466698
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2018-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02466698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02466698, "Intestinal Lavage for the Treatment of Severe C. Difficile Infections". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02466698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*